Repeat: Treatment.com AI Announces Release of New Medical Education Suite (MES) and Update on the AI Assessment Symposium 1st November, 2024
Treatment.com AI has announced the release of its updated Medical Education Suite (MES), coinciding with their participation in the AI Assessment Symposium at the University of Minnesota Medical School. The enhanced MES platform aims to support OSCE exams, taken by 200,000-300,000 medical students globally each year. New features include AI Patient for exam preparation, expanded OSCE Case Packages, and an AI Prep Tool with guided and non-guided learning options. The company plans further developments including AI Doctor in a Pocket and Audio/Video Analysis capabilities through 2024 and early 2025.
Treatment.com AI ha annunciato il rilascio della sua Suite di Educazione Medica (MES) aggiornata, in concomitanza con la loro partecipazione al Simposio di Valutazione AI presso la Scuola di Medicina dell'Università del Minnesota. La piattaforma MES potenziata mira a supportare gli esami OSCE, svolti ogni anno da 200.000 a 300.000 studenti di medicina a livello globale. Le nuove funzionalità includono Paziente AI per la preparazione agli esami, pacchetti di casi OSCE ampliati e uno strumento di preparazione AI con opzioni di apprendimento guidato e non guidato. L'azienda prevede ulteriori sviluppi, tra cui AI Dottore in tasca e capacità di analisi audio/video entro il 2024 e all'inizio del 2025.
Treatment.com AI ha anunciado el lanzamiento de su Suite de Educación Médica (MES) actualizada, coincidiendo con su participación en el Simposio de Evaluación de IA en la Facultad de Medicina de la Universidad de Minnesota. La plataforma MES mejorada tiene como objetivo apoyar los exámenes OSCE, realizados cada año por entre 200,000 y 300,000 estudiantes de medicina en todo el mundo. Las nuevas características incluyen Paciente AI para la preparación de exámenes, paquetes de casos OSCE ampliados y una herramienta de preparación AI con opciones de aprendizaje guiado y no guiado. La compañía planea más desarrollos, incluyendo AI Doctor en tu bolsillo y capacidades de análisis de audio/video hasta 2024 y principios de 2025.
Treatment.com AI는 미네소타 대학교 의대의 AI 평가 심포지엄에 참여하면서 업데이트된 의료 교육 솔루션(MES)의 출시를 발표했습니다. 향상된 MES 플랫폼은 매년 전 세계에서 20만~30만 명의 의대생들이 치르는 OSCE 시험을 지원하는 것을 목표로 합니다. 새로운 기능으로는 시험 준비를 위한 AI 환자, 확장된 OSCE 사례 패키지, 그리고 안내형 및 비안내형 학습 옵션을 제공하는 AI 준비 도구가 포함됩니다. 이 회사는 2024년과 2025년 초까지 'AI 주머니 속 의사' 및 오디오/비디오 분석 기능 등 추가 개발 계획을 세우고 있습니다.
Treatment.com AI a annoncé le lancement de sa Suite d'Éducation Médicale (MES) mise à jour, coïncidant avec leur participation au Symposium d'Évaluation de l'IA à l'École de Médecine de l'Université du Minnesota. La plateforme MES améliorée vise à soutenir les examens OSCE, passés chaque année par 200 000 à 300 000 étudiants en médecine dans le monde. Les nouvelles fonctionnalités incluent Patient IA pour la préparation aux examens, des paquets de cas OSCE élargis et un outil de préparation IA avec des options d'apprentissage guidé et non guidé. La société prévoit d'autres développements, y compris un médecin AI dans votre poche et des capacités d'analyse audio/vidéo d'ici 2024 et début 2025.
Treatment.com AI hat die Veröffentlichung seines aktualisierten Medizinischen Bildungsangebots (MES) angekündigt, zeitgleich mit ihrer Teilnahme am AI Assessment Symposium an der medizinischen Fakultät der Universität von Minnesota. Die verbesserte MES-Plattform zielt darauf ab, OSCE-Prüfungen zu unterstützen, die jährlich von 200.000 bis 300.000 Medizinstudenten weltweit abgelegt werden. Zu den neuen Funktionen gehören AI Patient zur Prüfungsvorbereitung, erweiterte OSCE-Fallpakete und ein AI-Vorbereitungstool mit geführten und ung geführten Lernoptionen. Das Unternehmen plant weitere Entwicklungen, darunter AI-Arzt in der Tasche und Audio-/Videoanalysefähigkeiten bis 2024 und Anfang 2025.
- Expansion of OSCE Case Packages from 12 to planned 100 cases by Q4 2024
- Introduction of new AI-powered features for medical education
- Large potential market with 200,000-300,000 medical students taking OSCE exams annually
- Lead commercial participation in major medical education symposium
- None.
●Treatment.com AI announces expanded and updated MES new releases
●Lead commercial participant at Global/North American Symposium on AI Assessment in Medical Education
●Further enhancements and solutions set for H2 2024
VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce the launch of its updated Medical Education Suite (MES) to coincide withTreatment’s participation in a landmark Symposium on AI Assessment in Medical Education being hosted by the University of Minnesota Medical School on 1st November 2024.
Medical Education Suite (MES) Release and Update
It is estimated that over 80 countries globally have now adopted the OSCE (Objective Structured Clinical Examination) for assessing the practical clinical skills of medical students. It is estimated that between 200,000 and 300,000 medical students globally take the OSCE exam each year, as derived from indicative numbers of students from key professional bodies including: https://www.aamc.org/; https://www.uems.eu/; https://www.nmc.org.in/; Education – GMC (gmc-uk.org)
As announced in a previous 2024 Press Releases,Treatment has been working diligently through 2024 to further evolve the Medical Education Suite (MES), powered by its proprietary Global Library of Medicine (GLM). The goal of furthering enhancements to the platform is the recognition that AI can be used even more effectively to reduce the administrative overhead and costs to schools in running OSCEs, as well providing greater support to medical students, thereby helping to optimize their clinical reasoning skills.
Treatment’s service comprises of using its Global Library of Medicine platform (GLM) in (i) creating cases for the OSCE exams (ii) producing scripts for actors playing the role of patients (iii) scoring the exams with our proprietary automated marking platform and (iv) providing instant results to both faculty and students, as well as offering student enrichment plans.
As part of this Release, Treatment is announcing the following additions to its portfolio:
- AI Patient – utilizing AI and a library of test Cases to further support students in their preparation and readiness for medical multiple-choice questions (MCQ’s) and OSCE exams.
- Objective Structured Clinical Examination (OSCE) Case Packages – the company is extending the number of test Cases provided from an initial 12 cases. These will be available in packs to schools and a planned library of up to 100 cases through Q4 2024.
- AI Prep Tool – the platform provides students with both a “guided” and “non-guided” support to learning. The “guided” approach provides students with learning support and reasoning, whereas the “non-guided” supports enables students to simulate exam conditions.
Symposium on AI Assessment in Medical Education
Together with the launch of its updated Medical Education Suite, Treatment is a lead participant in a Symposium on AI Assessment in Medical Education held on November 1, 2024 at the University of Minnesota Medical School, Office of Assessment and Evaluation. The creator of the Symposium, Dr. Claudio Violato described the event as a “landmark symposium”. (https://medtest.umn.edu/events)
This academic Symposium includes more than fifty medical schools, thought leaders and national education examiners from across the US, as well as international representation. Presenters include Mayo Clinic, University of Alberta as well as Treatment’s Chief Medical Officer Kevin Peterson, MD, MPH, who will be a keynote speaker, as an acknowledged leader in medical education and its utilization of AI.
Further enhancements and solutions for H2 2024
Treatment will continue to build out its Medical Education Suite through the rest of 2024 and early 2025. Further planned developments include:
AI Doctor in a Pocket – delivers a mobile friendly AI powered clinical decision support tool for healthcare professionals and students when they are in clinics, residency or on a hospital ward.
Audio/Video Analysis – using AI and the Global Library of Medicine to undertake Audio/Visual analysis which captures and transcribes the patient assessment. In addition, this will allow for behavioral analysis as part of exam scoring, as well as supporting the generation of a medical note.
Dr. Essam Hamza, CEO of Treatment.com AI, comments: “We are excited to showcase our updated Medical Education Software Suite at this landmark Symposium. The opportunity to have a positive impact on the medical training of students and in turn introduce them to our range of proprietary AI tools is an important inflection point in the company’s commercialization timeline. We look forward to updating the market further in the near future.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI and best clinical practices to positively disrupt the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). Providing highly qualified clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and has the propensity for greater consistency in quality of patient support. Treatment’s GLM platform also brings the possibility of health equity and inclusion for disenfranchised communities. To learn more about Treatment’s products and services: www.treatment.com or email: info@treatment.com
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
ehamza@treatment.com
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statements
This news release contains forward-looking statements that are based on Treatment.com AI’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although Treatment.com believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
FAQ
What new features did Treatment.com AI (TREIF) announce in their Medical Education Suite update?
How many OSCE cases will Treatment.com AI (TREIF) offer by Q4 2024?
What future developments did Treatment.com AI (TREIF) announce for H2 2024?
